Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 30 Sept 2026 for Rapport Therapeutics, Inc., €291k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
Cheryl Gault: trading record in brief
Cheryl Gault discloses dealings in Rapport Therapeutics, Inc. to SEC (Form 4). Between 30 June 2026 and 30 September 2026, the trades on record add up to 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 30 September 2026: a transaction of €291k, in Rapport Therapeutics, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Cheryl Gault
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
10,000 shares@ US$33.02CommonSEC144:0001950047-26-009884
10,000 shares@ US$40.390.025% mcap100.0% of flowCommonSEC144:0001950047-26-006648
2 of 2 declarations
